178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

by Jeff Hansen,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainViruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strain

COVID-19 virus rapidly evolves to higher infectivity during in vitro growth, which may be a step toward lower virulence

by Jeff Hansen,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainViruses accumulate mutations as they replicate in infected cells. Repeated replication can lead to viral strain
COVID-19 : Measuring viral RNA to predict which patients will die

COVID-19 : Measuring viral RNA to predict which patients will die

by University of MontrealColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIAI

COVID-19 : Measuring viral RNA to predict which patients will die

by University of MontrealColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIAI
Systemic inflammation increases risk for chronic kidney disease

Systemic inflammation increases risk for chronic kidney disease

by Lori SolomonSystemic inflammation is associated with an elevated risk for chronic kidney disease, according to a study published online Feb. 20 inFrontiers in Immunology.Xiaoxin Liu, from Ton

Systemic inflammation increases risk for chronic kidney disease

by Lori SolomonSystemic inflammation is associated with an elevated risk for chronic kidney disease, according to a study published online Feb. 20 inFrontiers in Immunology.Xiaoxin Liu, from Ton
Loosening chimeric antigen receptor's grip on T-regulatory cells improves function, researchers find

Loosening chimeric antigen receptor's grip on T-regulatory cells improves function, researchers find

by Leslie Cantu,Medical University of South CarolinaCAR and endogenous TCR/CD28 activation result in phenotypically similar Tregs. Credit:Molecular Therapy—Methods & Clinical Developme

Loosening chimeric antigen receptor's grip on T-regulatory cells improves function, researchers find

by Leslie Cantu,Medical University of South CarolinaCAR and endogenous TCR/CD28 activation result in phenotypically similar Tregs. Credit:Molecular Therapy—Methods & Clinical Developme
Risk of severe breakthrough COVID-19 infection is higher for people with HIV with moderately low CD4 cell counts

Risk of severe breakthrough COVID-19 infection is higher for people with HIV with moderately low CD4 cell counts

by Johns Hopkins University Bloomberg School of Public HealthGraphs show incidence of severe COVID-19 breakthrough illness by HIV status (A) (log-rank test P = .40), by CD4 cell count and HIV sta

Risk of severe breakthrough COVID-19 infection is higher for people with HIV with moderately low CD4 cell counts

by Johns Hopkins University Bloomberg School of Public HealthGraphs show incidence of severe COVID-19 breakthrough illness by HIV status (A) (log-rank test P = .40), by CD4 cell count and HIV sta
New assay may lead to a cure for debilitating inflammatory joint disease

New assay may lead to a cure for debilitating inflammatory joint disease

by New York University School of MedicineGregg Silverman, MD, Professor, Departments of Medicine and Pathology at NYU Langone Medical Center, and Director of its Musculoskeletal Center of Excelle

New assay may lead to a cure for debilitating inflammatory joint disease

by New York University School of MedicineGregg Silverman, MD, Professor, Departments of Medicine and Pathology at NYU Langone Medical Center, and Director of its Musculoskeletal Center of Excelle
How much of a boost do 'booster' COVID-19 jabs give?

How much of a boost do 'booster' COVID-19 jabs give?

by King's College LondonCredit: Pixabay/CC0 Public DomainScientists have found the "booster" COVID-19 vaccine program led to a large boost in the antibodies that help protect agains

How much of a boost do 'booster' COVID-19 jabs give?

by King's College LondonCredit: Pixabay/CC0 Public DomainScientists have found the "booster" COVID-19 vaccine program led to a large boost in the antibodies that help protect agains
Key protein linked to immune disorders

Key protein linked to immune disorders

by Hokkaido UniversityThe inflammatory reaction in spinal cords of STAP-1 knockout (KO) mice was less severe than that of wild type (WT) mice (top panels). In parallel, spinal cords of STAP-1 KO

Key protein linked to immune disorders

by Hokkaido UniversityThe inflammatory reaction in spinal cords of STAP-1 knockout (KO) mice was less severe than that of wild type (WT) mice (top panels). In parallel, spinal cords of STAP-1 KO
Discovery unveils immune system's guardian: Ikaros

Discovery unveils immune system's guardian: Ikaros

byMonash UniversityCredit: Pixabay/CC0 Public DomainIn a scientific breakthrough that aids our understanding of the internal wiring of immune cells, researchers at Monash University in Australia

Discovery unveils immune system's guardian: Ikaros

byMonash UniversityCredit: Pixabay/CC0 Public DomainIn a scientific breakthrough that aids our understanding of the internal wiring of immune cells, researchers at Monash University in Australia
Factors examined for time to first therapy for biologic DMARD in RA

Factors examined for time to first therapy for biologic DMARD in RA

(HealthDay)—For older patients with rheumatoid arthritis (RA), there is considerable variation in time to receipt of first biologic disease-modifying antirheumatic drug (DMARD) after prescription of t

Factors examined for time to first therapy for biologic DMARD in RA

(HealthDay)—For older patients with rheumatoid arthritis (RA), there is considerable variation in time to receipt of first biologic disease-modifying antirheumatic drug (DMARD) after prescription of t
Early and intensive treatment of rheumatoid arthritis reduces fatigue

Early and intensive treatment of rheumatoid arthritis reduces fatigue

by European League Against RheumatismCredit: CC0 Public DomainDisease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases. A Belgian s

Early and intensive treatment of rheumatoid arthritis reduces fatigue

by European League Against RheumatismCredit: CC0 Public DomainDisease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases. A Belgian s
Study finds cycling JAK inhibitors to be an effective option for patients with difficult-to-treat rheumatoid arthritis

Study finds cycling JAK inhibitors to be an effective option for patients with difficult-to-treat rheumatoid arthritis

by American College of RheumatologyCredit: Unsplash/CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that peo

Study finds cycling JAK inhibitors to be an effective option for patients with difficult-to-treat rheumatoid arthritis

by American College of RheumatologyCredit: Unsplash/CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that peo